Download Files:
Products Details
Product Description
– Cofirasersen is designed to reduce the expression of ENaC in the lung. ENaC is a sodium transport channel and believed to be hyperactive in cystic fibrosis, which is caused by mutations in the cystic fibrosis transmembrane regulator gene.
Web ID
– HY-139786
Shipping
– Room temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C172H218N57O88P15S15
References
– [1]WHO Drug Information, Vol. 34, No. 3, 2020
CAS Number
– 2247669-96-9
Molecular Weight
– 5437.55
SMILES
– [Cofiraserse]
Clinical Information
– Phase 2
Research Area
– Others
Solubility
– 10 mM in H2O
Target
– Sodium Channel
Pathway
– Membrane Transporter/Ion Channel
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
